Streamlined Authority | Pharmaceutical Benefits Scheme (PBS)

PBS Item code	Name, manner of administration and form & strength	Brand name & manufacturer	Streamlined authority code
5815C	Nafarelinnafarelin 200 microgram/actuation nasal spray, 60 actuations	Synarel[ PF ]	5046
8370M	Naltrexonenaltrexone hydrochloride 50 mg tablet, 30	ARX-NALTREXONE[ XT ]	13967
8370M	Naltrexonenaltrexone hydrochloride 50 mg tablet, 30	Naltrexone GH[ GQ ]	13967
1658G	Naproxennaproxen 125 mg/5 mL oral liquid, 474 mL	Phebra Naproxen Suspension[ FF ]	4159-4124
13820J	Natalizumabnatalizumab 150 mg/mL injection, 2 x 1 mL syringes	Tysabri[ BD ]	13625
13825P	Natalizumabnatalizumab 150 mg/mL injection, 2 x 1 mL syringes	Tysabri[ BD ]	13718
9505G	Natalizumabnatalizumab 300 mg/15 mL injection, 15 mL vial	Tysabri[ BD ]	13718
9624M	Natalizumabnatalizumab 300 mg/15 mL injection, 15 mL vial	Tysabri[ BD ]	13625
10714X	Netupitant + palonosetronnetupitant 300 mg + palonosetron 500 microgram capsule, 1	Akynzeo[ XT ]	14443
10731T	Netupitant + palonosetronnetupitant 300 mg + palonosetron 500 microgram capsule, 1	Akynzeo[ XT ]	14443
10319D	Nevirapinenevirapine 10 mg/mL oral liquid, 240 mL	Viramune[ BY ]	4512-4454
10304H	Nevirapinenevirapine 200 mg tablet, 60	Nevirapine Viatris[ AL ]	4512-4454
12868G	Nilotinibnilotinib 150 mg capsule, 120	Tasigna[ NV ]	18010
12858R	Nilotinibnilotinib 200 mg capsule, 120	Tasigna[ NV ]	17895
12867F	Nilotinibnilotinib 200 mg capsule, 120	Tasigna[ NV ]	17833
12885E	Nilotinibnilotinib 200 mg capsule, 120	Tasigna[ NV ]	12549
14231B	Nivolumabnivolumab 40 mg/4 mL injection, 4 mL vial	Opdivo[ BQ ]	18370
14232C	Nivolumabnivolumab 40 mg/4 mL injection, 4 mL vial	Opdivo[ BQ ]	15471
14233D	Nivolumabnivolumab 40 mg/4 mL injection, 4 mL vial	Opdivo[ BQ ]	15471
14260M	Nivolumabnivolumab 40 mg/4 mL injection, 4 mL vial	Opdivo[ BQ ]	18370
15224G	Nivolumabnivolumab 40 mg/4 mL injection, 4 mL vial	Opdivo[ BQ ]	18070
15238B	Nivolumabnivolumab 40 mg/4 mL injection, 4 mL vial	Opdivo[ BQ ]	18070
14231B	Nivolumabnivolumab 100 mg/10 mL injection, 10 mL vial	Opdivo[ BQ ]	18370
14232C	Nivolumabnivolumab 100 mg/10 mL injection, 10 mL vial	Opdivo[ BQ ]	15471
14233D	Nivolumabnivolumab 100 mg/10 mL injection, 10 mL vial	Opdivo[ BQ ]	15471
14260M	Nivolumabnivolumab 100 mg/10 mL injection, 10 mL vial	Opdivo[ BQ ]	18370
15224G	Nivolumabnivolumab 100 mg/10 mL injection, 10 mL vial	Opdivo[ BQ ]	18070
15238B	Nivolumabnivolumab 100 mg/10 mL injection, 10 mL vial	Opdivo[ BQ ]	18070
10150F	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	Abraxane[ TS ]	4657
10150F	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	nab-PACLITAXEL JUNO[ JU ]	4657
10165B	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	Abraxane[ TS ]	4657
10165B	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	nab-PACLITAXEL JUNO[ JU ]	4657
4531L	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	Abraxane[ TS ]	6106-6119
4531L	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	nab-PACLITAXEL JUNO[ JU ]	6106-6119
7270P	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	Abraxane[ TS ]	6106-6119
7270P	nanoparticle albumin-bound paclitaxelpaclitaxel (as nanoparticle albumin-bound) 100 mg injection, 1 vial	nab-PACLITAXEL JUNO[ JU ]	6106-6119
12996B	nirmatrelvir (&) ritonavirnirmatrelvir 150 mg tablet [4] (&) ritonavir 100 mg tablet [2], 5 x 6	Paxlovid[ PF ]	16155-16223-16192-16156
14664T	nivolumab + relatlimabnivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial	Opdualag[ BQ ]	16881
14676K	nivolumab + relatlimabnivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial	Opdualag[ BQ ]	16151
14677L	nivolumab + relatlimabnivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial	Opdualag[ BQ ]	16151
14678M	nivolumab + relatlimabnivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial	Opdualag[ BQ ]	16881

Last updated

1 June 2026